The role of recombinant activated factor VII in cardiac surgery
Recombinant factor VIIa may reduce surgical blood loss and transfusion of blood products in cardiac surgery. However, the true risks of its use in this setting remains to be elucidated, especially when it is administered with other potent pro-haemostatic agents. We reviewed the recent literature on...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
EDIMES Edizioni Internazionali Srl
2009
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484551/ |